BRNS vs EFX · $38.2M cap vs P/E 54, rev $3.35B
Barinthus Biotherapeutics plc (BRNS) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
BRNS currently screens at market cap $38.2M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the BRNS and EFX stock pages for the full models.
Not investment advice.